Detalles de la búsqueda
1.
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors.
Clin Proteomics
; 21(1): 24, 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38509475
2.
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
Oncologist
; 28(8): 730-736, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255276
3.
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
Gynecol Oncol
; 171: 129-140, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893489
4.
Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy.
Oncology (Williston Park)
; 36(8): 492-498, 2022 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36001788
5.
Predictors and Outcomes of Surgery in Peritoneal Mesothelioma: an Analysis of 2000 Patients from the National Cancer Database.
Ann Surg Oncol
; 27(8): 2974-2982, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32006127
6.
ASO Author Reflections: Expert Surgical Evaluation is Critical for Patients with Diffuse Malignant Peritoneal Mesothelioma: Lessons Learned from Assessing Outcomes of 2000 Patients.
Ann Surg Oncol
; 27(8): 2983-2984, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274661
7.
RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data.
Curr Treat Options Oncol
; 16(7): 33, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26050230
8.
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; : JCO2302078, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748939
9.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561967
10.
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 7: e2300385, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096472
11.
Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?
Oncologist
; 17(12): 1541-6, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22622148
12.
Patient attendance at molecular tumor board: A new means of shared decision making?
Curr Probl Cancer
; 46(3): 100860, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436642
13.
Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
Cancer Treat Res Commun
; 32: 100569, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567913
14.
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
JCO Precis Oncol
; 6: e2200191, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409971
15.
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476331
16.
Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study.
JCO Oncol Pract
; 17(9): e1286-e1292, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793345
17.
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
J Clin Oncol
; 39(22): 2443-2451, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844595
18.
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
J Clin Oncol
; 39(2): 155-169, 2021 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33290128
19.
Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 4: 757-766, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050752
20.
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Target Oncol
; 15(6): 733-741, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33090333